Finally, we identified strong evidence for a detrimental effect of higher FHL3 expression on both overall and male-specific CRC risk across several subtypes of CD4+ T cells during rest and at three post-activation timepoints (Figure 5). Here, CD4 is linked to colorectal carcinoma.